| Dr Grace Caldwell, MD | |
|
1400 W 22nd St, Sioux Falls, SD 57105-1554 | |
| (605) 322-5737 | |
| Not Available |
| Full Name | Dr Grace Caldwell |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1400 W 22nd St, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285216788 | NPI | - | NPPES |
| Entity Name | St Cloud Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043269798 PECOS PAC ID: 4880594779 Enrollment ID: O20110221000134 |
News Archive
In the first MRI-based study to investigate pre-natal alcohol exposure, researchers found significant changes in the brain structure of fetuses exposed to alcohol compared to healthy controls. Results of the study are being presented today at the annual meeting of the Radiological Society of North America (RSNA).
Men with localized prostate cancer treated with a newer technology, intensity modulated radiation therapy (IMRT), have more than a quarter (26 percent) fewer late bowel and rectal side effects and a statistically improved lower dose of radiation to the bladder and rectum, compared to those who undergo 3D-CRT, according to a randomized study presented at the plenary session October 3, 2011, at the 53rd Annual Meeting of the American Society for Radiation Oncology.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
The first clinical trial to investigate whether treatment with a statin drug can reduce the increased cardiovascular disease risk in people infected with HIV has begun enrolling patients. Based at Massachusetts General Hospital, the six-year, $40 million REPRIEVE (Randomized Study to Prevent Vascular Events in HIV) trial will be conducted at around 100 sites in the U.S., Canada, Puerto Rico and Thailand with funding from the National Heart, Lung, and Blood Institute in collaboration with the AIDS Clinical Trials Group and support from the National Institutes of Allergy and Infectious Diseases.
A report by federal health care inspectors in November said the U.S. nursing home industry overbills Medicare $1.5 billion a year for treatments patients don't need or never receive.
› Verified 6 days ago
| Entity Name | Carris Health Llc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1134632680 PECOS PAC ID: 7012274228 Enrollment ID: O20180111000831 |
News Archive
In the first MRI-based study to investigate pre-natal alcohol exposure, researchers found significant changes in the brain structure of fetuses exposed to alcohol compared to healthy controls. Results of the study are being presented today at the annual meeting of the Radiological Society of North America (RSNA).
Men with localized prostate cancer treated with a newer technology, intensity modulated radiation therapy (IMRT), have more than a quarter (26 percent) fewer late bowel and rectal side effects and a statistically improved lower dose of radiation to the bladder and rectum, compared to those who undergo 3D-CRT, according to a randomized study presented at the plenary session October 3, 2011, at the 53rd Annual Meeting of the American Society for Radiation Oncology.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
The first clinical trial to investigate whether treatment with a statin drug can reduce the increased cardiovascular disease risk in people infected with HIV has begun enrolling patients. Based at Massachusetts General Hospital, the six-year, $40 million REPRIEVE (Randomized Study to Prevent Vascular Events in HIV) trial will be conducted at around 100 sites in the U.S., Canada, Puerto Rico and Thailand with funding from the National Heart, Lung, and Blood Institute in collaboration with the AIDS Clinical Trials Group and support from the National Institutes of Allergy and Infectious Diseases.
A report by federal health care inspectors in November said the U.S. nursing home industry overbills Medicare $1.5 billion a year for treatments patients don't need or never receive.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Grace Caldwell, MD 6005 S Hallow Ave, Sioux Falls, SD 57106-8709 Ph: (312) 982-4144 | Dr Grace Caldwell, MD 1400 W 22nd St, Sioux Falls, SD 57105-1554 Ph: (605) 322-5737 |
News Archive
In the first MRI-based study to investigate pre-natal alcohol exposure, researchers found significant changes in the brain structure of fetuses exposed to alcohol compared to healthy controls. Results of the study are being presented today at the annual meeting of the Radiological Society of North America (RSNA).
Men with localized prostate cancer treated with a newer technology, intensity modulated radiation therapy (IMRT), have more than a quarter (26 percent) fewer late bowel and rectal side effects and a statistically improved lower dose of radiation to the bladder and rectum, compared to those who undergo 3D-CRT, according to a randomized study presented at the plenary session October 3, 2011, at the 53rd Annual Meeting of the American Society for Radiation Oncology.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
The first clinical trial to investigate whether treatment with a statin drug can reduce the increased cardiovascular disease risk in people infected with HIV has begun enrolling patients. Based at Massachusetts General Hospital, the six-year, $40 million REPRIEVE (Randomized Study to Prevent Vascular Events in HIV) trial will be conducted at around 100 sites in the U.S., Canada, Puerto Rico and Thailand with funding from the National Heart, Lung, and Blood Institute in collaboration with the AIDS Clinical Trials Group and support from the National Institutes of Allergy and Infectious Diseases.
A report by federal health care inspectors in November said the U.S. nursing home industry overbills Medicare $1.5 billion a year for treatments patients don't need or never receive.
› Verified 6 days ago
Dr. Alex James Linn, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1301 S Cliff Ave Ste 610, Sioux Falls, SD 57105 Phone: 605-322-8860 Fax: 605-322-8868 | |
Amber Olson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W 69th St, Sioux Falls, SD 57108 Phone: 605-322-4005 | |
Dr. Robert Floyd Nuss, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W. 69th St., Ste. 1500, Sioux Falls, SD 57108 Phone: 605-322-5700 | |
Sarah A Flynn, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W 69th St, Ste 1500, Sioux Falls, SD 57108 Phone: 605-322-5700 Fax: 605-322-5704 | |
Mackenzie Mertz, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2400 W 49th St, Sioux Falls, SD 57105 Phone: 605-312-8700 | |
Georgiana Nuss, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2400 W 49th St, Sioux Falls, SD 57105 Phone: 605-312-8700 | |
Hannah Statz Devries, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W 69th St Ste 1500, Sioux Falls, SD 57108 Phone: 605-322-5700 |